Evaluation of Safety and Immunogenicity of Combined Immunization of PPV23 and IIV4
Conditions: Influenza, Human; Pneumonia, Pneumococcal Interventions: Biological: IIV4 and PPV23; Biological: IIV4; Biological: PPV23 Sponsors: China National Biotec Group Company Limited; Fujian Provincial Center for Disease Control and Prevention; Chengdu Institute of Biological Products Co.,Ltd.; Changchun Institute of Biological Products Co., Ltd.; National Institutes for Food and Drug Control, China; Guizho u Center for Disease Control and Prevention; Hunan Provincial Center for Disease Control and Prevention; Peking University Recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials
More News: Centers for Disease Control and Prevention (CDC) | China Health | Influenza | Pneumonia | Research